In the United States, prescribing rules are more flexible
The 13 states where Medicaid covers GLP-1 drugs for obesity are California, Kansas, Minnesota, Wisconsin, Michigan, Mississippi, Pennsylvania, Virginia, North Carolina, Massachusetts, New Hampshire, Delaware and Rhode Island
At InCare, our support extends beyond the injectionwell help you set realistic goals, monitor your progress, and celebrate your achievements along the way
Targeting cerebral incretin and insulin receptors appears to show promise for neurodegenerative conditions, perhaps through neuroprotective mechanisms including reducing cell death and inflammation whilst enhancing neurogenesis
Eating smaller, frequent meals